Skip to main content
. 2014 Jun 20;5(14):5472–5482. doi: 10.18632/oncotarget.2121

Figure 7. Increased Glo-1 activity in triple negative cells exposed to chronic treatment with MG.

Figure 7

Glo-1 activity was measured in triple negative MDA-MB-231 and in ER/PR positive MCF-7 cells after three weeks treatment with low doses of MG. A significant increase of Glo-1 activity was observed only in triple negative cells. Results are the average of 4 independent experiments. Data were statistically analyzed with two-way ANOVA followed by Bonferroni multiple comparisons (* p ≤ 0.05, **p ≤ 0.01 and ***p ≤ 0.001 vs untreated cells).